How we're using AI tools to improve psychedelic-drug research
Briefly

How we're using AI tools to improve psychedelic-drug research
Lucy is an artificial-intelligence-powered tool created to improve training for people who facilitate psychedelic-assisted therapy. Trained facilitators are needed to support individuals receiving psychedelic treatments for mental-health conditions. Multiple psychedelic drugs, including psilocybin, MDMA, ibogaine, and LSD, are in clinical trials for disorders such as PTSD, depression, and substance-use disorders. These therapies require rigorous clinical oversight and hours-long sessions that can be emotionally challenging for both clients and facilitators. As legal access expands in places like Oregon, Colorado, and New Mexico, demand for facilitators is expected to rise. A global shortage of mental-health providers could worsen in this emerging, specialized field. Lucy aims to reveal what effective psychological support looks like and generate data that could inform public-health policy on drug regulation.
"Trained facilitators are needed to assist individuals who are undergoing psychedelic therapy for mental-health conditions. Several psychedelic drugs, including psilocybin, MDMA (also known as ecstasy), ibogaine and LSD, are in clinical trials for conditions ranging from post-traumatic stress disorder (PTSD) and depression to substance-use disorders. Rigorous clinical trials require trained professionals to administer these drugs and oversee hours-long therapy sessions that are often emotionally challenging for both client and facilitator."
"As treatments that use psychedelic drugs gain further clinical approval, and as more US states consider legalizing the use of psychoactive substances for therapy purposes, the demand for facilitators is likely to increase. Today, adults in Oregon and Colorado can legally consume psilocybin if supervised by licensed facilitators, and New Mexico plans to launch a programme for the medical use of psilocybin this year. Yet, there is a global shortage of mental-health providers, and this is likely to be even more severe in psychedelic-assisted therapy because it is an emerging field that requires specialized training."
"Schoeller discusses the approach to designing Lucy, how the AI platform is revealing what effective psychological support looks like and how data from Lucy could inform public-health policies around drug regulation. What inspired Lucy? Joshua told me about his non-profit organization Fireside Project, which operates a free support phone line, run by trained volunteers, for people seeking guidance during their psychedelic experiences. Fireside Project records its calls for training purposes, and its dat"
Read at Nature
Unable to calculate read time
[
|
]